Clinical Trial

Assessing the Effect of an Antioxidant-Rich Diet on Metabolic Syndrome Risk Using the Dietary Antioxidant Index

Study acronym: AD-MetS-DAI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Metabolic syndrome (MetS) is a cluster of metabolic disorders characterized by elevated levels of blood glucose, hypertension, dyslipidemia, and abdominal obesity. Globally, it is a major public health concern. International studies have linked higher Dietary Antioxidant Index with reduced risk of MetS, as antioxidants play a role in lowering the risk of MetS by reducing oxidative stress, a key contributor to its pathophysiology. Exploring this link in Pakistan can provide valuable insights for dietary strategies to reduce the risk of MetS.
Trial Details
NCT Number NCT07354438
Lead Sponsor University of Veterinary and Animal Sciences, Lahore - Pakistan
Conditions Metabolic Syndrome Risk Factors
Enrollment 55 participants
Start Date 2026-01-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-21